Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Evaluate after-tax yields across bond options in retirement to determine which bond yields the most income after taxes.
26,078 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
With $500 in hand, the big question is where to invest for the best balance of growth and risk. This article compares...
This deep dive breaks down NextPlat's Q1 2026 earnings, translating the numbers into practical takeaways for investor...
Two prominent analysts lifted price targets on Newell Brands, sparking a rally where the stock raced higher. This art...
Investors spotted a notable move in the mining space as Coeur Mining stock popped after an earnings beat. This piece ...
NVIDIA’s GTC keynote spotlighted two moves that could reshape AI hardware and software. This guide breaks down the hi...
The Trade Desk faced another slide as investors weighed AI-driven competition and fee pressure. This deep dive breaks...
A single insider move often sparks headlines, but context matters. This article digs into what this credo insider's s...
A major stake sale in Albertsons by a large hedge fund sparks questions about what insiders know and how it affects t...
A deadly LaGuardia collision puts the spotlight on air-traffic control fatigue, staffing gaps, and how these issues r...
Nio has introduced a budget-focused EV to widen its market. This analysis spells out what the move means for investor...
As the calendar closes on 2025, Ascendis (ASND) faces the final earnings closeout with questions about cash, pipeline...